Jyoti Resins Q2 FY27: revenue +31% YoY, margin compression caps PAT growth at 8%
PAT +7.69% YoY · revenue +31.31% · margins compressing
₹97.67 Cr
+31.31% YoY
₹18.48 Cr
+7.69% YoY
18.38%
-3.8pp YoY
₹15
Jyoti Resins' standalone revenue grew 31.3% YoY to ₹97.67 Cr (from ₹74.38 Cr in Q2 FY26), but net profit rose only 7.7% YoY to ₹18.48 Cr (from ₹17.16 Cr), as margins compressed: OPM fell to 23.04% from 27.52% a year ago, and NPM to 18.38% from 22.13%. The squeeze traces mainly to raw-material cost — cost of materials consumed plus the change in inventories (the two lines together approximate the true input-cost run-rate) rose to ₹36.20 Cr from ₹20.28 Cr a year ago, a 78.5% jump that outpaced revenue growth by a wide margin. Sequentially the picture improved — PAT is up 57.3% QoQ and OPM/NPM both expanded sharply from Q1 FY27's trough (OPM 14.43%→23.04%, NPM 12.92%→18.38%) — but that recovery is off a weak base: Q1 FY27 itself had posted a 32% YoY PAT decline, so this quarter's sequential bounce is a partial recovery rather than fresh strength, and YoY remains the harder read — profit growth trailing revenue growth by roughly 24 points is the real story.
Q2 FY-2027 vs prior quarters
No street/consensus estimates for this micro-cap turned up in a search, so vsStreet is unknown; no management press release accompanied this filing beyond the regulatory board-outcome letter, so there is no fresh management commentary to reconcile against the numbers. Against the FY29 targets laid out in the August 2026 concall (₹500 Cr revenue, 23-25% EBITDA margin, 15-20% volume growth, a new 3,500-tonne/month line targeted for Q2 FY27, and normalizing 120-day receivables within two quarters), this quarter's OPM of 23.04% sits at the low end of the margin band — on-track but not yet comfortably inside it — while the filing gives no update on the new capacity's commissioning status. Trade receivables stood at ₹161.66 Cr at September 30, 2026, up 25.6% YoY from ₹128.70 Cr, with no sign yet of the stated normalization; the two-quarter window set in August points to Q3 FY27 as the checkpoint. Separately, the company secured NSE listing approval on October 7, 2026, a liquidity/visibility milestone unrelated to this quarter's operating numbers.
The stock went into the print at ₹884.9, up 4.4% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
EPS ₹15 (basic) vs ₹14 a year ago and ₹10 last quarter
FY29 revenue target ₹500 Cr with 23-25% EBITDA; 15-20% volume growth; New 3,500-tonne/month capacity (₹600-650 Cr revenue potential) ready Q2 FY27; Aim to normalize 120-day receivables within 2 quarters.
W1
Receivables normalization checkpoint: management targeted normalizing 120-day receivables within 2 quarters of the Aug 2026 concall; receivables at ₹161.66 Cr show no improvement yet — Q3 FY27 is the stated deadline
W2
New 3,500-tonne/month capacity (₹600-650 Cr revenue potential cited) was targeted for Q2 FY27; this filing gives no commissioning update — confirm status next quarter
W3
OPM at 23.04% sits at the low end of management's 23-25% FY29 EBITDA band — watch whether the QoQ margin recovery (14.43%→23.04%) continues or raw-material costs push it back down
Only standalone statement filed (no consolidated section); no exceptional items either period; other income includes an immaterial ₹59.16 lakh reversal of excess earlier-years depreciation (Ind AS 8 note); all figures converted from ₹ Lakh to ₹ Crore.
Informational and educational content only. Not investment advice.